Redman Progress in Research Integrity

Defining and Managing Conflict of Interest
Erscheinungsjahr 2026
ISBN: 978-3-032-27479-3
Verlag: Springer International Publishing
Format: PDF
Kopierschutz: 1 - PDF Watermark

E-Book, Englisch, 204 Seiten

Reihe: Medicine (R0)

This book follows Dr. Redman’s 2023 book,  by addressing in much greater depth one of the most consequential but ill-defined constructs in research integrity – conflict of interest (COI). COI in biomedical research is ubiquitous but so poorly defined that its frequency and consequences can rarely be identified. Many research sectors and actors have little to no guidance about how to identify and manage their own COI or those of the institutions and sectors in which they work. In addition, while the current political climate casts doubt on the existence/relevance of COI, the starkness of its tactics can provide an opportunity to move COI management beyond even the current level considered acceptable.

is ideal for research administrators, policy advisors, researchers, and consultants. 

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Redman, Barbara K.

Inhaltsverzeichnis

Section I  Definition of Conflict of Interest, and State of Its Regulation in  Science and Practice .- Chapter 1: .Conflict of Interest As a Disorder of Research Integrity- Chapter 2: Conflicts of Interest in Healthcare and Biomedical Science: Mechanisms, Moral Responsibility, and Procedurally Just Management.- Chapter 3: Medical research and individual researcher conflict of interest: what is happening and what is to be done.- Chapter 4 Best Practices for COI Management in Research.- Section 2 Innovative Ways Forward .-Chapter 5: Identifying Conflicts of Interest in Research by Artificial Intelligence.- Chapter 6: Addressing conflicts of interest in clinical trials.- Chapter 7: Institutional Use of Meta-Research to Manage Conflict of Interest.- Chapter 8: Perspectives from the Policy Sciences.- Chapter 9: Conflict of Interest in Journal Quality Assessment: Bridging Strengths and Gaps.- Section III Philosophical/Political/Historical  Base and Case Studies . Chapter 10: Managing Conflicts of Interest in Citizen Science.- Chapter 11: Intermediary or Invisible Actor? A Qualitative Study of the Role, Risks, and Perceptions of a Non-Profit Clinical Research Funding Organization in Japan.- Chapter 12 Progress in Research Integrity: Identifying and Addressing Conflicts of Interest in Pain Medicine.- Chapter 13: Case:  Conflict of Interest to Challenge Harmful Commercial Determinants of Health.- Chapter 14: Avenues for Conflict of Interest Management in Research.

Über Autor(innen)

Barbara K. Redman is Associate, Division of Medical Ethics, NYU Grossman School of Medicine. She has an extensive list of publications in research integrity, research misconduct and research ethics in general. Through a Fogarty training grant to NYU and the University of Ghana, Dr. Redman teaches research integrity to Ghanian Fogarty Fellows who are addressing, through empirical and theoretical work, issues of research integrity in their own country. As a Senior Fellow in the GE2P2 Global Foundation, she leads teams providing consultation on issues of research integrity to large and small global pharmaceutical/biotech companies. Dr. Redman has served the US Office of Research Integrity as a research grant reviewer and as a Special Consultant. She served for several years on the Wayne State University School of Medicine IRB and has been a reviewer for a wide range of bioethics and related journals.

In addition to the PhD, Dr. Redman holds a masters degree in bioethics from the University of Pennsylvania, was a Visiting Scholar at the Kennedy Institute of Ethics, Georgetown University, a Fellow in Medical Ethics at Harvard Medical School, a Senior Fellow at the University of Pennsylvania Center for Bioethics and a Network Fellow at the Edmond J. Safra Center for Ethics at Harvard University. She holds honorary doctorates from Georgetown University and the University of Colorado.